Daftar Isi
1. Low-Grade Serous Ovarian Cancer Updates (2025)
Dr. Rachel Grisham of and Dr.
2. Dr. Gershenson on Evolution of Targeted Therapies for Rare Gynecologic Malignancies
3. Developments & Advances in Low Grade Serous Ovarian Cancer
Developments & Advances in Low Grade Serous Ovarian Cancer Speaker: Dr.
4. David Gershenson A Tribute to his friend Bobby Darin
With huge thanks to Jamie Ney, we present here a lengthy tribute to Bobby from his friend
5. OC 360 LIVE: Dr. David Gershenson
Welcome to OC 360 LIVE! In this Ask The Expert session Dr.
6. Society of Gynecologic Oncology 50th Anniversary: David Gershenson, MD
The Society of Gynecologic Oncology has grown in many different ways over the past 50 years. SGO Past President
7. David Gershenson on Challenges to Advancing Treatment for Rare Ovarian Cancers
View more at curetoday.com/ CURE: Combining science and humanity to make cancer understandable.
8. Unraveling Ovarian Cancer: New Treatment Of Rare Sub-types
9. David Gershenson, MD, tells us what's new in the treatment of rare epithelial cancers
10. David Gershenson, MD, on considerations for maintenance therapy in ovarian cancer
11. Promising Advances in Low Grade Serous Ovarian Cancer
Speaker: Dr.
12. Understanding Low-Grade Serous Ovarian Cancer: Treatments, Trials, and What's Next
Join Dr.
13. Management Challenges of Low Grade Serous Ovarian/Peritoneal Cancer - David Gershenson
This presentation is part of a series of presentations given at the 2016 Continuing Professional Development (CPD) Meeting ...
14. Two decades of progress in the understanding of LGSOC
15. Dr. David Gershenson at FWC - National Race to End Women's Cancer 2011
Gynecologic Oncologist at MD Anderson and Chairman of the Board of Directors for the Foundation for Women's Cancer, Dr.
David Gershenson Information Guide
Background to David Gershenson
Key Details
Recent Updates
Deep Dive
Data is compiled from public records and verified media reports.
Last Updated: August 13, 2026
Conclusion
Disclaimer: Disclaimer: All information is compiled from publicly available data, media reports, and analysis. Actual details may vary.